Interval between Removal of a 4.7 mg Deslorelin Implant after a 3-, 6-, and 9-Month Treatment and Restoration of Testicular Function in Tomcats

Simple Summary Gonadotropin-releasing hormone (GnRH) agonists bind to GnRH receptors in the anterior pituitary causing an initial release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) followed by a desensibilization of the GnRH receptors. On the first days of treatment, this results in an increase in testosterone secretion in males, while in females, it may induce an estrous cycle. This is commonly referred to “flare-up effect” and its duration depends on the active substance and the dose. After this initial stimulation, pituitary GnRH receptors are downregulated with a consequent decrease in ovarian and testicular activity. In tomcats, researchers found that testosterone levels rapidly decline 20 days after the insertion of a 4.7 mg deslorelin implant, remaining at basal levels (below 0.1 ng/mL) for a prolonged period of time. However, there is a high individual variability in the response to treatment, and the duration of efficacy varies between 6 and 24 months. As a consequence of basal testosterone levels, testicular volume decreases, and sexual behavior and penile spines disappear. All of these effects are completely reversible once the implant is not active any longer or following implant removal. Abstract Deslorelin implants have been used to produce a reversible sterilization in several species. In cats, the prolonged duration (12–15 months in tomcats and 18–22 months in queen) is often too much for cat breeders who request early implant removal. The interval between implant removal and resumption of reproductive function in cats has never been investigated. Eighteen tomcats received a 4.7 mg deslorelin implant placed in the periumbilical area and surgically removed during all seasons of the year after 3, 6, or 9 months (n = 6, 6, and 6 cats, respectively). Following implant removal, all cats received a clinical exam every two weeks, including testicular ultrasonographic measurement, observation of penile spikes, and blood collection for serum testosterone assay. Restoration of serum testosterone secretion occurred after 23 ± 6, 23 ± 6, and 22 ± 7 days in the 3-, 6-, and 9-month groups, respectively. Restoration of testicular function was confirmed by histology in 13/15 cats undergoing orchiectomy at the end of the study while the owners of the remaining two cats opted to maintain their animals intact. Removal of a 4.7 mg deslorelin implant after 3, 6, or 9 months is followed by resumption of serum testosterone secretion after about 3 weeks independent of age or season.

[1]  A. Fontbonne,et al.  Contraceptive implants used by cat breeders in France: a study of 140 purebred cats , 2020, Journal of feline medicine and surgery.

[2]  S. Romagnoli,et al.  Length of efficacy and effect of implant location in adult tom cats treated with a 9.4 mg deslorelin subcutaneous implant , 2018, Journal of feline medicine and surgery.

[3]  S. Goericke-Pesch Long-term effects of GnRH agonists on fertility and behaviour. , 2017, Reproduction in domestic animals = Zuchthygiene.

[4]  S. Romagnoli,et al.  Postponement of puberty in queens treated with deslorelin , 2017, Journal of feline medicine and surgery.

[5]  S. Romagnoli,et al.  Use of the gonadotropin‐releasing hormone (GnRH) stimulation test to monitor gonadal function in intact adult male cats , 2017, Reproduction in domestic animals = Zuchthygiene.

[6]  J. Thuróczy,et al.  Effect of deslorelin on testicular function, serum dihydrotestosterone and oestradiol concentrations during and after suppression of sexual activity in tom cats , 2017, Journal of feline medicine and surgery.

[7]  D. Zambelli,et al.  First deliveries after estrus induction using deslorelin and endoscopic transcervical insemination in the queen. , 2015, Theriogenology.

[8]  C. Fontaine Long-term contraception in a small implant , 2015, Journal of feline medicine and surgery.

[9]  P. Čížek,et al.  Azoospermia with variable testicular histology after 7 months of treatment with a deslorelin implant in toms. , 2015, Theriogenology.

[10]  C. Phillips,et al.  A Reproductive Management Program for an Urban Population of Eastern Grey Kangaroos (Macropus giganteus) , 2014, Animals.

[11]  A. Wehrend,et al.  Suppression of fertility in adult cats. , 2014, Reproduction in domestic animals = Zuchthygiene.

[12]  S. Schäfer-Somi,et al.  Suppression of fertility in pre-pubertal dogs and cats. , 2014, Reproduction in domestic animals = Zuchthygiene.

[13]  S. Johnston,et al.  Inhibition of the Reproductive System by Deslorelin in Male and Female Pigeons (Columba livia) , 2014, Journal of avian medicine and surgery.

[14]  M. Veronesi,et al.  Effectiveness of deslorelin acetate subcutaneous implantation in a domestic queen with after-spaying urinary incontinence , 2014, Journal of feline medicine and surgery.

[15]  A. Wehrend,et al.  Treatment of queens in estrus and after estrus with a GnRH-agonist implant containing 4.7 mg deslorelin; hormonal response, duration of efficacy, and reversibility. , 2013, Theriogenology.

[16]  R. L. de la Sota,et al.  Effect of natural photoperiod on epididymal sperm quality and testosterone serum concentration in domestic cat (Felis silvestris catus). , 2012, Reproduction in domestic animals = Zuchthygiene.

[17]  S. Romagnoli,et al.  Semen quality and onset of sterility following administration of a 4.7-mg deslorelin implant in adult male dogs. , 2012, Reproduction in domestic animals = Zuchthygiene.

[18]  P. Čížek,et al.  Reversible suppression of sexual activity in tomcats with deslorelin implant. , 2012, Theriogenology.

[19]  E. Trevisol,et al.  Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens. , 2012, Theriogenology.

[20]  A. Wehrend,et al.  Clinical efficacy of a GnRH-agonist implant containing 4.7 mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Sandra.Pesch@vetmed.uni-giessen.de. , 2011, Theriogenology.

[21]  F. de Jong,et al.  Use of a gonadotropin releasing hormone agonist implant as an alternative for surgical castration in male ferrets (Mustela putorius furo). , 2008, Theriogenology.

[22]  Y. Ogawa,et al.  Testicular volume measurement: comparison of ultrasonography, orchidometry, and water displacement. , 2007, Urology.

[23]  L. Munson Contraception in felids. , 2006, Theriogenology.

[24]  D. Zambelli,et al.  Semen collection in cats: techniques and analysis. , 2005, Theriogenology.

[25]  A. Padula GnRH analogues--agonists and antagonists. , 2005, Animal reproduction science.

[26]  T. Trigg,et al.  Applications of GnRH in the control and management of fertility in female animals. , 2005, Animal reproduction science.

[27]  G. Martin,et al.  Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs. , 2003, Reproduction, fertility, and development.

[28]  L. R. França,et al.  Testis Morphometry, Seminiferous Epithelium Cycle Length, and Daily Sperm Production in Domestic Cats (Felis catus) , 2003, Biology of reproduction.

[29]  A. Atala,et al.  Testicular volume: comparison of orchidometer and US measurements in dogs. , 2002, Radiology.

[30]  G. Martin,et al.  Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. , 2001, Journal of reproduction and fertility. Supplement.

[31]  C. Asa,et al.  Efficacy of the GnRH analogue deslorelin for suppression of oestrous cycles in cats. , 2001, Journal of reproduction and fertility. Supplement.